Short Interest in Neuralstem Expands By 3.9% (CUR)
Shares of Neuralstem (NYSE:CUR) were the recipient of a significant growth in short interest during the month of July. As of July 31st, there was short interest totalling 9,983,880 shares, a growth of 3.9% from the July 15th total of 9,611,785 shares, AnalystRatingsNetwork.com reports. Currently, 12.0% of the shares of the stock are short sold. Based on an average daily volume of 702,872 shares, the short-interest ratio is currently 14.2 days.
CUR has been the subject of a number of recent research reports. Analysts at Aegis reiterated a “buy” rating on shares of Neuralstem in a research note on Friday.
Shares of Neuralstem (NYSE:CUR) traded up 3.33% on Monday, hitting $3.41. The stock had a trading volume of 469,770 shares. Neuralstem has a 1-year low of $1.43 and a 1-year high of $4.81. The stock’s 50-day moving average is $3.48 and its 200-day moving average is $3.72. The company’s market cap is $295.9 million.
Neuralstem (NYSE:CUR) last posted its quarterly earnings results on Friday, August 8th. The company reported ($0.08) EPS for the quarter, missing the Thomson Reuters consensus estimate of ($0.05) by $0.03. Analysts expect that Neuralstem will post $-0.25 EPS for the current fiscal year.
Neuralstem, Inc is a development-stage company focused on the development and commercialization of treatments for central nervous system disease based on transplanting human neural stems cells and the use of small molecule drugs.